Gerald D. Cagle, Director at AERIE PHARMACEUTICALS INC (AERI), bought 1,854 shares at $15.07 ($28K) on 2014-05-16, disclosed to the SEC on 2014-05-20.
Open-market purchase of $28k AERI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| AERI | BUY | 2018-05-25 | $49K | — | Filing → |
| AERI | BUY | 2018-05-22 | $50K | — | Filing → |
| CLSD | BUY | 2018-03-23 | $89K | — | Filing → |